7,270 Shares in Prothena Co. plc (NASDAQ:PRTA) Bought by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. purchased a new position in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) during the 1st quarter, Holdings Channel.com reports. The firm purchased 7,270 shares of the biotechnology company’s stock, valued at approximately $352,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the […]

Related Keywords

Arizona ,United States ,China ,American ,Wagnerm Zago ,Hideki Garren ,American International Group Inc ,Prothena Co ,China Universal Asset Management Co ,Cantor Fitzgerald ,Oppenheimer Co ,Prothena Company Profile ,Holdings Channel ,Capula Management Ltd ,Principal Financial Group Inc ,Prothena Corporation ,Nasdaq ,Free Report ,State Retirement System ,Financial Group ,International Group ,Management Ltd ,China Universal Asset Management ,Universal Asset Management ,Get Free Report ,Visit Holdingschannel ,Prothena Daily ,Prothena ,Nasdaq Prta ,Pprta ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,